Skip to main content
. 2018 Jun 22;11(4):971–978. doi: 10.1016/j.tranon.2018.05.011

Figure 3.

Figure 3

Analysis of IGF-II autocrine signaling in Hep3B and HepG2 cells following DX-2647 treatment. (A) Immunoprecipitation analysis of IR and IGF-IR from cell lysates treated with vehicle or 20 μg/ml DX-2647 for 48 hours followed by blotting for total IR, total IGF-IR, and pan-phosphotyrosine (p-Y99). (B) Western blotting of IR and IGF-IR receptor status and downstream signaling status in cell lysates isolated from Hep3B and HepG2 cells treated with vehicle or 20 μg/ml DX-2647 for 48 hours.